title: Recalcitrant pemphigus herpetiformis with high titer of immunoglobulin G antibody to desmoglein 1 and positive IgG antibody to desmocollin 3, elevating thymus and activation-regulated chemokine.
authors: Department of Dermatology, Yokohama City University Medical Center, Yokohama, Japan.
authors: Setsuko
authors: S
authors: Matsukura
authors: Kazuo
authors: K
authors: Takahashi
authors: Michiko
authors: M
authors: Hirokado
authors: Yuko
authors: Y
authors: Ikezawa
authors: Kazuko
authors: K
authors: Nakamura
authors: Shunpei
authors: S
authors: Fukuda
authors: Takashi
authors: T
authors: Hashimoto
authors: Zenro
authors: Z
authors: Ikezawa
authors: Michiko
authors: M
authors: Aihara
authors: Takeshi
authors: T
authors: Kambara
mesh_terms: D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D054414:Chemokine CCL17 / Q000097:blood*; D003622:Dapsone / Q000627:therapeutic use; D051187:Desmocollins / Q000276:immunology*; D051183:Desmoglein 1 / Q000276:immunology*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D010392:Pemphigus / Q000097:blood* / Q000628:therapy*; D010956:Plasmapheresis; D011239:Prednisolone / Q000627:therapeutic use; D019233:Retreatment
chemical_list: D000893:Anti-Inflammatory Agents; D054414:Chemokine CCL17; C490356:DSC3 protein, human; D051187:Desmocollins; D051183:Desmoglein 1; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D003622:Dapsone; D011239:Prednisolone